Buserelin vs Human Chorionic Gonadotropin (HCG)
A synthetic GnRH agonist that suppresses hormones to help treat prostate cancer, endometriosis, and infertility
A powerful hormone that mimics luteinizing hormone (LH) to stimulate your body's natural testosterone production while keeping your fertility intact—like having your cake and eating it too for men on hormone therapy.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Quick comparison
Dose range
Buserelin
200–200 mcg
Human Chorionic Gonadotropin (HCG)
500–1500 IU
Frequency
Buserelin
Once daily
Human Chorionic Gonadotropin (HCG)
Twice weekly
Administration
Buserelin
Subcutaneous injection
Human Chorionic Gonadotropin (HCG)
Subcutaneous injection
Cycle length
Buserelin
Ongoing/indefinite
Human Chorionic Gonadotropin (HCG)
Ongoing/indefinite
Onset speed
Buserelin
Moderate (1-2 weeks)
Human Chorionic Gonadotropin (HCG)
Moderate (1-2 weeks)
Evidence level
Buserelin
Strong human trials (Phase 3 or FDA approved)
Human Chorionic Gonadotropin (HCG)
Strong human trials (Phase 3 or FDA approved)
Benefit ratings
Hormone Suppression
Cancer Management
Fertility Support
Fertility Preservation
Testicular Health
Hormone Balance
Compound specifications
Buserelin
Molecular formula
C60H86N16O13
Molecular weight
1239.4 g/mol
Half-life
2-4 hours (subcutaneous), 30-60 minutes (intranasal); longer for depot formulation (28-40 days)
Bioavailability
~1% (oral); ~10-15% (intranasal); ~95% (subcutaneous)
CAS number
57773-65-6
Human Chorionic Gonadotropin (HCG)
Molecular formula
C1105H1770N318O336S26 (approximate)
Molecular weight
36,700 g/mol (approximately)
Half-life
24-36 hours
Bioavailability
High when injected subcutaneously or intramuscularly
CAS number
9002-61-3
Dosing compared
Buserelin
Subcutaneous
500 mcg
Every 8 hours (3 times daily) · First 7 days
The product label starts prostate cancer treatment with 500 mcg under the skin every 8 hours for the first week [5].
200 mcg
Once daily · Ongoing maintenance
After the first week, the label switches to 200 mcg once daily under the skin for ongoing treatment [5].
Intranasal
400 mcg (2 sprays per nostril)
3 times daily (1,200 mcg/day) · Ongoing maintenance
The nasal spray option delivers 400 mcg three times a day as maintenance, an alternative to daily injections [5].
Implant
6.3 mg
Once every 2 months · Long-term
A long-acting implant placed under the skin slowly releases buserelin over about 2 months, so no daily dosing is needed [5].
9.45 mg
Once every 3 months · Long-term
A larger implant lasts about 3 months between placements [5].
Human Chorionic Gonadotropin (HCG)
Subcutaneous
500-1,500 IU
2-3 times per week · Ongoing with TRT
Documented clinical practice for preserving testicular function/fertility in men on testosterone therapy; 1,500-2,000 IU 2-3x/week is used for hypogonadotropic hypogonadism [6]. The popular 500 IU 2-3x/week maintenance figure reflects real-world practice rather than the FDA label. In controlled dosing, 250 IU every other day held intratesticular testosterone within 7% of baseline and 500 IU raised it 26% above baseline during testosterone administration [7]; 500 IU every other day preserved semen parameters with no azoospermia in men on TRT [8].
Intramuscular
500-1,000 IU
3 times weekly for 3 weeks, then 2 times weekly for 3 weeks · 6-week induction course
FDA-labeled regimen for male hypogonadotropic hypogonadism (Pregnyl) [7]. Intramuscular is the only labeled route.
4,000 IU then taper to 2,000 IU
3 times weekly · 4,000 IU for 6-9 months, then 2,000 IU for 3 additional months
Higher-dose FDA-labeled regimen for inducing spermatogenesis/testicular descent (Pregnyl) [7].
Best suited for
Buserelin
Managing advanced prostate cancer
Buserelin is particularly well-suited for individuals focused on managing advanced prostate cancer. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Treating endometriosis and reducing associated pain
Buserelin is particularly well-suited for individuals focused on treating endometriosis and reducing associated pain. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Optimizing ovarian response during fertility treatments
Buserelin is particularly well-suited for individuals focused on optimizing ovarian response during fertility treatments. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Human Chorionic Gonadotropin (HCG)
Fertility Preservation During TRT
If you're on testosterone therapy but want to keep your swimmers swimming, HCG is your best friend. It keeps your testes active and producing sperm even when external testosterone would normally shut that down. Research shows it can maintain or restore spermatogenesis in about 80% of men [3][4][8].
Preventing Testicular Atrophy
Nobody wants their boys to shrink. When you take external testosterone, your brain stops signaling your testes to work—and they get smaller from disuse. HCG mimics the signal (LH) that keeps them active, maintaining their size and function [6][14].
Hypogonadotropic Hypogonadism
If your pituitary gland isn't sending the right signals to your testes (low LH), HCG can step in and do the job. It's been used for decades to treat this condition, helping men achieve normal testosterone levels and fertility [3][6][13].
Post-Cycle Therapy (PCT)
After using anabolic steroids, your natural hormone production is suppressed. HCG can help jumpstart your testes back into action, speeding up the recovery of your natural testosterone production. It's often used as part of a comprehensive PCT protocol [9][15].
Side effects
Buserelin
Human Chorionic Gonadotropin (HCG)
Common
- Injection site reactions
- Headache
- Water retention
Uncommon
- Gynecomastia
- Mood changes
- Acne
Serious
- Blood clots
Safety & evidence
Buserelin
Evidence level
Strong human trials (Phase 3 or FDA approved)
FDA status
FDA approved for other use
Safety overview
Buserelin is an FDA-approved GnRH agonist with safety data from Phase 3 trials and decades of clinical use, but carries well-documented risks from intentional testosterone/estrogen suppression. The initial testosterone flare (first 2-3 weeks) can worsen prostate cancer symptoms and cause tumor flare pain in 10-20% of patients. Long-term use causes bone density loss of 2-3% annually, with vertebral fractures in 10-20% of long-term users. Cardiovascular risks include increased MI and stroke in men over 65. Hot flashes affect 40-80%, erectile dysfunction is nearly universal, and liver enzyme elevations occur in 5%. Nasal spray formulation causes local irritation in 20-30% of users.
Contraindications
- Pregnancy or breastfeeding
- Hypersensitivity to GnRH agonists
- Certain bone diseases when long-term use is planned
Human Chorionic Gonadotropin (HCG)
Evidence level
Strong human trials (Phase 3 or FDA approved)
FDA status
FDA approved for other use
Safety overview
HCG has been used medically for over 80 years with a well-established safety profile. [10] When used appropriately for male hypogonadism or fertility preservation, side effects are generally mild and manageable. The most common issues relate to elevated estrogen from increased testosterone aromatization, which can be managed with aromatase inhibitors if needed. [6][18] Serious side effects are rare when HCG is used under medical supervision.
Contraindications
- Hormone-sensitive cancers (prostate, breast)
- Precocious puberty in children
- Known allergy to HCG or any component
- Pregnancy (in therapeutic male contexts)
- Untreated thyroid or adrenal disorders
Which is right for you?
Choose Buserelin if...
- Managing advanced prostate cancer
- Treating endometriosis and reducing associated pain
- Optimizing ovarian response during fertility treatments
Choose Human Chorionic Gonadotropin (HCG) if...
- Fertility preservation during TRT
- Maintaining testicular size and function
- Natural testosterone stimulation
- Post-cycle therapy recovery